Table 2.
Clinical outcomes in 14 patients with long-COVID after 20 days of treatment with H1 and H2 receptor blockers, and in 13 untreated patients with long-COVID.
| Symptoms | Treated patients (n = 14) | Untreated patients (n = 13) | ||||
|---|---|---|---|---|---|---|
| At baseline (%) | Unchanged 20 days after (%) | p-Value | At baseline (%) | Unchanged 20 days after (%) | p-Value | |
| Fatigue | 100 | 21 | <0.0001 | 100 | 85 | 0.4800 |
| Brain fog | 93 | 43 | 0.0127 | 85 | 70 | 0.6447 |
| Increased HR | 93 | 29 | 0.0013 | 92 | 85 | 1.0000 |
| Abdominal disorders | 79 | 14 | 0.0048 | 77 | 62 | 0.6727 |
HR, heart rate.